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What is already known about the topic?
x Home is often considered the preferred place of care and death for most people.
x Hospital deaths occur more often in patients with haematological than other cancers.
x Relatives accounts of their own and decedents preferences, and their reflections on the factors influencing their 
achievement, are unexplored in haematological malignancies.
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Abstract
Background: People with haematological malignancies have different end-of-life care patterns from those with other cancers 
and are more likely to die in hospital. Little is known about patient and relative preferences at this time and whether these are 
achieved.
Aim: To explore the experiences and reflections of bereaved relatives of patients with leukaemia, lymphoma or myeloma, and 
examine (1) preferred place of care and death; (2) perceptions of factors influencing attainment of preferences; and (3) changes that 
could promote achievement of preferences.
Design: Qualitative interview study incorporating Framework analysis.
Setting/participants: A total of 10 in-depth interviews with bereaved relatives.
Results: Although most people expressed a preference for home death, not all attained this. The influencing factors include disease 
characteristics (potential for sudden deterioration and death), the occurrence and timing of discussions (treatment cessation, 
prognosis, place of care/death), family networks (willingness/ability of relatives to provide care, knowledge about services, confidence 
to advocate) and resource availability (clinical care, hospice beds/policies). Preferences were described as changing over time and 
some family members retrospectively came to consider hospital as the right place for the patient to have died. Others shared 
strong preferences with patients for home death and acted to ensure this was achieved. No patients died in a hospice, and relatives 
identified barriers to death in this setting.
Conclusion: Preferences were not always achieved due to a series of complex, interrelated factors, some amenable to change and 
others less so. Death in hospital may be preferred and appropriate, or considered the best option in hindsight.
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What this paper adds?
x This is the first study to examine preferred place of care and death in patients with blood cancers from the perspectives 
of bereaved relatives.
x Factors impacting on achievement of preferences were disease characteristics, the occurrence and timing of end-of-life 
discussions, family networks and resource availability.
x Hospital was sometimes preferred and, on reflection, some relatives identified this as the right place for the patient to 
have died.
Implications for practice, theory or policy
x Early, honest and realistic communication of risk and uncertainty, initiated by haematologists, could prevent over-opti-
mism and facilitate advance planning among patients and relatives, as well as allowing primary care staff adequate time 
to prepare for the patients potential death at home.
x Standardisation of hospice policies could result in this service being better able to meet the needs of patients with hae-
matological malignancies.
x Relatives are key members of the caregiving team; their reflections were new, insightful and important.
Introduction
Haematological malignancies are complex cancers 
broadly categorised as leukaemias, lymphomas and mye-
loma; they affect all age groups, but are common in older 
people.1 Collectively, these diseases represent around 8% 
of all new cancers diagnosed annually in the United 
Kingdom (UK).2 They can be highly aggressive or indolent, 
with treatment varying in intensity and being given for dif-
fering purposes.3 For example, chemotherapy may be 
administered as a course (i.e. with a specific number of 
cycles); it can be given intermittently (e.g. at times of 
relapse/progressive disease), or constantly (e.g. daily 
without a planned end date); and it can be given to induce 
and maintain remission, for disease control, or to improve 
quality of life.
Despite significant treatment advances, many haema-
tological malignancies remain incurable, have unpredict-
able and uncertain trajectories, and highly variable 
outcomes that are particularly poor for some subtypes.46 
Deterioration may be unexpected and sudden or gradual, 
as response to chemotherapy diminishes. This can com-
plicate decision-making regarding treatment cessation, 
initiation of end-of-life discussions and ascertainment of 
care preferences.
End-of-life pathways are recognised to differ for patients 
with haematological malignancies from other cancers. 
People with blood cancers, in the United Kingdom and 
elsewhere, are more likely to receive hospital-based inten-
sive treatments close to the end of life;7,8 less likely to 
receive palliative and/or hospice care,9,10 or to receive this 
closer to death, when they are seriously ill;11,12 and more 
likely to die in hospital than at home or in a hospice.1315
Studies indicate that most people would prefer to die at 
home16,17 and that their family caregivers often support 
this decision.18 However, such assertions are increasingly 
being questioned. A recent systematic review of the UK lit-
erature, for example, highlights the scale and impact of 
missing data in studies about place of death and the result-
ing lack of clarity around preference for home death.19 
Another study, based on interviews with 59 bereaved fam-
ily carers of older people dying at home, revealed the com-
plex and often overpowering emotions that may be 
associated with home death, which led the authors to 
question if this setting is necessarily better than the oth-
ers.20 Other interviews, exploring end-of-life hospital use 
by patients with palliative care needs, found that beyond 
treatment patients also appreciated being cared for by 
staff with expert knowledge of their condition, as this 
made them feel safe and brought relief for family mem-
bers.21 Symptom outcomes are also said to be better for 
individuals dying in hospital, compared to home.22
To date, little is known about preferred place of care 
and death in patients with haematological cancers and 
their families. We therefore conducted interviews with 
bereaved relatives of patients with these diseases, one 
strand of a larger qualitative study that included inter-
views with haematology doctors and nurses, GPs and pal-
liative care clinicians.23,24 The aim of the interviews with 
relatives was to explore (1) preferred place of care and 
death; (2) reflections on experiences following the 
patients death, including perceptions of factors influenc-
ing the attainment of preferences; and (3) changes that 
could promote achievement of preferences.
Methods
We used qualitative methods (in-depth interviews), 
described below in accordance with the consolidated cri-
teria for reporting qualitative studies (COREQ).25
Setting and participants
The study was set within the United Kingdoms 
Haematology Malignancy Research Network (HMRN: 
www.hmrn.org), a collaborative programme of work 
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involving researchers and clinical staff, which was estab-
lished in 2004 to generate evidence to improve patient 
care,26 using various methodologies, including qualitative 
research. For the present project, haematologists at a sin-
gle hospital in the HMRN area purposively identified the 
main bereaved family care provider(s) of patients with 
leukaemia, lymphoma or myeloma, who had died within 
the previous 2 years (maximum). Potential interviewees 
were then sent an information sheet about the study and 
an invitation to take part. Inclusion was not limited by 
place of death or end-of-life preferences and whether 
these had been met.
Individuals who wanted to take part were asked to 
contact a researcher (D.A.H.) to arrange an interview. In 
total, 13 relatives were approached and 10 agreed to be 
interviewed (Table 1). Sample size was determined ethi-
cally and pragmatically. Due to the sensitive nature of 
the topic, we did not want to conduct more interviews 
than necessary, nor did we wish to overburden the hae-
matologists facilitating recruitment. Data saturation 
(when no new or relevant information is forthcoming27) 
was, therefore, deemed unlikely and so was not an aim 
of the study.
Data collection and analysis
Written consent was obtained before each interview and 
assurances given concerning confidentiality and anonym-
ity. Interviews were conducted in 2014 (eight in relatives 
homes and two in a private university office), with the aid 
of a semi-structured topic guide (Table 2), sufficiently flex-
ible to incorporate new lines of inquiry. Interviews lasted 
up to 90 min and were audio-recorded and transcribed 
verbatim.
The Framework method was used to analyse the 
data.28 Framework is a flexible tool, not aligned with a par-
ticular epistemological, philosophical or theoretical stance, 
but adaptable to various qualitative approaches aiming to 
generate themes. It facilitates the identification of com-
monalities and differences in qualitative data, focusing on 
the relationships between different data segments, with 
the aim of drawing descriptive and/or explanatory conclu-
sions clustered around themes.29 Our analytical approach 
was predominantly deductive; that is to say, it was guided 
by the research questions, derived from the relevant litera-
ture. It followed the systematic sequential steps: data 
familiarisation (by reading and re-reading transcripts); 
identification of codes and development of a coding 
scheme that was applied to individual transcripts, 
expanded and modified as necessary to accommodate 
data; aggregation of codes (units of meaning) and theme 
development; summarising and charting of data (using 
electronic spreadsheets to facilitate comparison within 
and between cases); and cross-comparison of themes 
throughout the dataset to promote synthesis and 
interpretation.28 Negative or deviant cases were sought 
in the data and used to develop and refine the analysis.30
Interviews were conducted by D.A.H. and data analysis 
was led by D.M., with guidance from D.A.H. D.M. and 
D.A.H. (both former registered nurses and experienced 
Table 1. Characteristics of relative participants and decedents.
Study 
ID
Participant characteristics Decedent characteristics Months between 
patients death and 
relatives interviewRelationship 
to decedent
Gender Diagnosis Age at death 
(years)
Gender Survival 
(months)
R1 Spouse F Leukaemia 67 M 6 10
R2 Daughter F Myeloma Unknown F Unknown Unknown
R3 Spouse/
Daughter
M/F Lymphoma 81 F 22 3
R4 Spouse F Myeloma 75 M 8 21
R5 Spouse F Lymphoma 71 M 4 5
R6 Spouse F Lymphoma 80 M 51 9
R7 Spouse F Lymphoma 74 M 18 7
R8 Spouse F Leukaemia 66 M 93 9
R9 Spouse M Leukaemia 66 F 31 4
R10 Spouse F Leukaemia 69 M 5 6
Table 2. Topic guide.
x Discussions regarding broad end-of-life issues (treatment failure/cessation, prognosis)
x Discussions regarding preferred place of care and death, and changes over time
x Was preferred place of care and death achieved? If not why not
x Factors considered to have prevented/promoted death at home/hospital
x Key changes that could facilitate care and death in the preferred place
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qualitative researchers) regularly discussed and refined 
codes and emerging themes. Disagreements facilitated 
refinement of the analysis.31 An independent researcher 
(R.H.) assessed the fit of the coding scheme of two inter-
views,32 confirming that the strategy was comprehensive 
and appropriate.33
Ethical approval. National Health Service (NHS) ethical 
approval was obtained from Yorkshire and The Humber 
Research Ethics Committee (REC: 11/YH/0306).
Results
The characteristics of interviewees are shown in Table 1. 
More decedents were men than women; more women 
than men were interviewees and these were mainly 
spouses, with the exception of two daughters. We 
included relatives whose family members had had leukae-
mia, lymphoma and myeloma, with patients ages ranging 
from 66 to 81 years and survival spanning 493 months. 
Most relatives were interviewed within 310 months of 
the patients death. Results are presented (with verbatim 
quotations), according to three key themes.
Theme 1: preferred place of care and place 
of death
Relatives discussed their own and the patients preferred 
and actual place of care and death (Table 3). Preferences 
changed over time, with differing views sometimes 
described between patients and their relatives. Home 
was the most common preference, then hospice; no 
patients, and only one interviewee (R4), were inclined 
towards hospital death. Six patients died at home, four in 
hospital and none in hospice.
Several relatives (R7, R8, R9) reported sharing patients 
strong preference for home care and death, which 
remained unchanged as the patients condition declined. 
Death anywhere but home was considered highly undesir-
able by these interviewees, who portrayed themselves as 
advocates, prepared to speak up to ensure patients died 
at home:
he wanted to stay at home  I wasnt going to have him go in 
[to hospital] because he didnt want to  the night he was 
dying he was getting restless and I said will you let me get the 
doctor , No, no, theyll take me [to hospital]  and I said 
no, they wont  I wouldnt have let him go back in  (R7)
Hospice was cited as the fall back option for some 
people whose first preference was for death at home. One 
relative (R1) said she had wanted her husband to die in 
hospice to avoid future painful associations of him having 
died in the family home:
she was very clear that she wanted to die at home, and if she 
couldnt, then it would have been in the hospice if at all 
possible, she absolutely did not want to be in hospital. (R9)
I didnt want him to die at home  it would have brought too 
many memories  I would have been quite happy for him to 
go into hospice. (R1)
R5s husband had expressed a preference for hospice 
care, though her own inclination had been for him to die 
at home. However, when her husband developed distress-
ing symptoms, he was urgently admitted to hospital, 
where he died:
Table 3. Patients (reported) and relatives (expressed) preferred place of death, changes over time and actual place of death.
Study 
ID
Patients 
PPD
Relative 
PPD
Patients change of 
preference
Relatives change of 
preference
Actual place 
of death
R1 Home Hospice He couldnt have 
cared (after sudden 
deterioration)
Hospital death was very 
peaceful and care was 
good
Hospital
R2 Hospice Home Home Unchanged Home
R3 Not stated Not stated Not stated Not stated Home
R4 Not stated Hospital Not stated Not stated Hospital
R5 Hospice Home Not stated With hindsight, hospital 
was the right place for 
husband to die (after 
sudden deterioration)
Hospital
R6 Not stated Home Not stated Unchanged Home
R7 Home Home Unchanged Unchanged Home
R8 Home Home Unchanged Unchanged Home
R9 Home Home Unchanged Unchanged Home
R10 Home Unsure Not stated Hospital was the right 
place (for husband to die)
Hospital
PPD: preferred place of death.
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he wanted the final chapter of his life to be in the hospice  
he didnt want to die in hospital  but he was coughing up 
blood and couldnt get his breath. (R5)
Only one participant (R4) indicated having held a pref-
erence for her spouse to receive end-of-life care in hospi-
tal, due to anxiety about her ability to provide adequate 
care at home. Her preference was for her husband to 
receive professional support in a nearby hospital, where 
she could visit without restriction. Reflecting on his death, 
this interviewee noted the high-quality care her husband 
had received during his final weeks, which had convinced 
her that death in hospital had been appropriate:
the hospital was half a mile away  I could be there in five 
minutes  they made us feel totally involved and welcomed 
 the staff nurses and nursing assistants were wonderful  
For us hospital was the right place, if wed been at home we 
would have been stressed  that we werent doing the right 
thing  I was very grateful for that professional support  he 
was needing two people to help him go to the loo  he was 
very weak  I dont know how I could have managed at home 
without someone with me. (R4)
Similarly, several relatives (R1, R5, R10), whose spouses 
had not wished to die in hospital but had done so, stated 
that with hindsight they had come to view the patients 
death in hospital as appropriate and acceptable, partly 
because (re)admission had brought expert nursing care 
and symptom relief. These relatives suggested that they 
would have struggled to care for the patient at home, par-
ticularly overnight, when assistance from community 
nurses could be unreliable. However, a sense of failure 
associated with relinquishing responsibility for caring for 
their spouse was apparent in some accounts:
I felt Id failed him in some way with him having to go back in 
[to hospital], but I know he was really frightened when he 
couldnt take his breath during the night  and he felt a lot 
safer on the ward where he could get help incredibly quickly 
 the support we got couldnt have been better  in the end 
it was the right place. (R5)
Place of death was reported as less significant to some 
patients in their final hours than feeling safe and secure in 
a familiar environment, cared for by people they knew 
and trusted. One relative (R1), whose husband had 
wanted to die at home, described his death in a small 
community hospital as very peaceful:
those last 48 hours, I dont think he really cared [where he 
was]  there was something about [hospital] that made it 
more user friendly  it was small, it was more intimate  it 
was less clinical and he liked the staff  he didnt like a big 
[hospital]. (R1)
Contrastingly, enabling home death appeared vitally 
important to relatives for whom dying at home was 
intrinsic to their notion of a good death. R2, for example, 
expressed a desire to give her mother a good death at 
home. As a nurse, she said she had felt competent to 
manage her mothers symptoms and needs at home, with 
support from family and community nursing services. This 
relative recounted positive memories of her mothers 
lovely death, which she felt had drawn family members 
together:
she [mother] had a good death at home  it was lovely  
even when she was breathing her last we were ringing this 
friend of hers saying do you want to come round and say 
goodbye. (R2)
Theme 2: factors perceived to influence 
achievement of preferred place of care and 
death
Four inter-related factors were perceived as influencing 
achievement of preferences: disease characteristics, the 
occurrence and timing of end-of-life discussions, family 
networks and resource availability. These are summarised 
in Figure 1.
Disease characteristics. A major obstacle relatives identi-
fied to attainment of preferences was the unpredictability 
of the patients disease. Sudden deterioration, alongside 
the onset of distressing symptoms, resulted in relatives 
contacting haematology services, the General Practitioner 
(GP) or out-of-hours medical services, for advice and 
assistance. Consequently, some patients previously dis-
charged home to die were readmitted to hospital, where 
they subsequently died. Such events were said to have 
occurred even when there was input from community 
palliative care nurses:
with this kind of illness, events overtake themselves, they 
[patients] have a downturn and they need immediate 
attention and your first port of call is the hospital  they have 
this raging temperature and they need immediate medical 
assistance  antibiotics and blood transfusions, fluids, so you 
ring the helpline and they get you in. (R1)
Sudden decline in the patients condition could mean 
that discharge home, or hospice transfer (from hospital), 
was not always desirable or feasible at this time:
it would have been really cruel to move him when he 
suddenly went downhill that quickly  he was far better 
supported by people who really knew him instead of him 
having to travel [to hospice] when he was feeling terrible  
to a situation where we didnt know anybody. (R5)
Occurrence and timing of discussions about treatment 
cessation, prognosis and place of care and death. The 
occurrence and early introduction of end-of-life discus-
sions appeared important for meeting preferences for 
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Figure 1. Factors perceived to impact on achievement of preferred place of care and death (home or hospice).
McCaughan et al. 7
home death, particularly if care-packages required organ-
ising to facilitate this. Most relatives recalled at least one 
discussion with a haematologist concerning treatment 
cessation in the months/weeks preceding the patients 
death; they recalled being told that there was nothing 
more to be done in terms of treatment and that they had 
run out of options. Some people commented that it had 
been clearly explained at diagnosis that the effectiveness 
of treatment would diminish over time, a message rein-
forced in follow-up consultations:
when the cancer originally happened [haematologist] gave a 
percentage  [chance of] cure  and then when [patient] 
went back  it was definitely not such a good recovery rate  
[Haematologist] did tell us that before [patient] even started 
the chemo  so my husband knew that his chances were 
much worse. (R6)
Others said that they had experienced feelings of shock 
as, at diagnosis, they believed that they had been told the 
patients condition, although not curable, was treatable. 
This had led some relatives and patients to remain pre-
dominantly optimistic that a new treatment might stop 
their disease progressing:
[Haematologist] told us it wasnt curable but it was treatable, 
it just always made us feel hopeful that they would treat it  
[Haematologist] was so good at trying everything and 
anything. (R8)
In other cases, it was only after the patients (re)admis-
sion to hospital due to deterioration that discussions indi-
cated treatment was failing and the patient was going to 
die imminently:
we got into the hospital, and then it was made clear  and 
we began to understand where we were going. (R3)
In such cases, relatives recalled being asked about pre-
ferred place of care and death, but described patients as 
being too ill to make considered decisions at this juncture. 
Moreover, options were limited if, for example, a hospice 
bed was required for terminal care, but not immediately 
available:
there wasnt a hospice bed available. (R5)
One person had attended a multidisciplinary meeting 
to discuss her spouses preferences, but found the experi-
ence intimidating and overwhelming:
I found it incredibly daunting  youre going as a relative 
stranger into a room full of people, who all know each other 
and  everybody is coming at it from all their different 
points of view  I just felt utterly bombarded and 
overwhelmed  it was horrible  I felt trapped  inside 
youre screaming. (R5)
Another relative said that they would have appreciated 
earlier discussion concerning decreasing response to 
treatment and likelihood of death. Yet, despite attempts 
by haematologists, relatives portrayed most patients as 
reluctant to engage in end-of-life conversations, either 
with clinicians or with their family:
the earlier you discuss it, the better, frankly  when she 
firstly was told at the hospital of a 20% chance of survival, at 
that point, somebody ought to have come and had a 
discussion with her. (R9)
[Haematologist] was upfront  but he [patient] didnt want 
to know. (R7)
He [patient] wouldnt discuss it  he was frightened of dying 
 he was never good at dealing with anything emotive  he 
couldnt come to terms with it. (R1)
Relatives described how late discussions resulted in 
patients returning home from hospital at short notice, 
with little time to organise support from relatives and/or 
community nursing services:
the consultant said  there was really no more [he/she] 
could do and [he/she] came into the [hospital] room and told 
him that  They did ask him where he wanted to go and he 
said, Id like to go home and there was a meeting between 
the GP surgery and various staff to try and have that happen 
 I was quite frightened at the thought of him coming home 
 because they [community nursing services] couldnt 
promise any night care. (R10)
Doctors were said to be reluctant to predict prognosis 
after treatment cessation, and several relatives had been 
shocked and unprepared for how quickly death had 
ensued following hospital discharge:
they never said time is short  there was no weeks or months 
 they didnt give us a time-span  and I wasnt ready [for 
parents death]. (R2)
Relatives focussed on aspects of haematologists com-
munication skills that had made end-of-life discussions 
easier or more difficult. An open, honest approach, with 
sufficient time for dialogue, was described positively, 
while an abrupt attitude was perceived as disengaging:
we had every confidence in [haematologist, who] was 
excellent and explained everything beautifully. (R6)
it was abrupt  a bit full on for him [patient]  in your face  
wed only been in [the room] a minute or two and [the 
haematologist] just looked at him and said Do you know 
where you want to die?. (R1)
Family networks. Having relatives at home, or nearby, 
who could provide physical care and emotional support 
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was considered essential for patients to remain at home. 
Some interviewees described themselves as too frail for 
this, while others were disinclined to carry out intimate 
tasks, seen as undignified for the patient, preferring 
instead to pay for assistance. Relatives experienced in 
delivering hands-on nursing care said that they had felt 
confident in looking after the patient at home:
Im not very big  I was just terrified that he would fall 
because I thought, if he falls, Ill never get him up by myself. 
(R8)
having to change him, he was very embarrassed  youve got 
to think of the persons dignity. (R10)
[paid carers] helped with bed bath and cleaned and tidied 
[patient]. (R3)
I was a carer  we did the course at college for palliative care 
 Id been nursing for a long time  in the community. (R7)
The benefits of the wider family pulling together to 
support the patient to remain at home were noted by 
many respondents: family cohesion  the whole family 
worked at it (R3). Relatives who advocated for patients 
to remain at home at the end of their lives, if this was 
their choice, rather than being (re)admitted to hospital 
(see Theme 1), said that they did not feel their views 
were always given due consideration by the community 
health care team. Those with prior knowledge or experi-
ence of community nursing or hospice services remarked 
that this had helped them access services on behalf of 
patients. Others (e.g. R3 and daughter), who described 
themselves as complete amateurs in a professional 
world, relied on health care professionals to inform them 
about services:
I know how the system works  we got her fast tracked, 
equipment appeared  we got the Marie Curie nurse to stay 
on an evening and  I put a bit of emphasis on getting the 
Macmillan [nurse] on board  and she said, lets take you to 
the day hospice, Id like you to meet the consultant in 
palliative care  and everything was sorted out. (R2; 
community nurse)
he was not offered any chance to go into hospice  it would 
have been nice to have had the option  (R10)
Having prior contact with outpatient hospice services 
seemed influential in consideration of inpatient hospice 
care; but policy regarding the delivery of supportive care 
in this setting and the potential for this to vary between 
sites was said to restrict some patients accessing this 
resource:
we managed to get my mum to the day hospice, which she 
really enjoyed  and she agreed to admission to the hospice 
as well. (R2)
if his calcium had shot up and he needed more treatment, 
[hospice] wouldnt have done it, they would have sent him 
back to hospital. (R6)
Several relatives mentioned feeling let down by the 
lack of support for themselves as caregivers; only one per-
son reported receiving written information to prepare 
them for what to expect at the time of their relatives 
death:
some [nurses] are very good but some are not up to palliative 
care, cos youre not just there for the patient, youre there 
for the relative as well. (R7)
I didnt know what happens when people die  but the Marie 
Curie nurse left a little booklet  that was very, very helpful. 
(R6)
Resource availability. Adequate nursing support (e.g. dis-
trict, Macmillan and Marie Curie nurses) was considered 
essential for relatives to provide care at home, and gaps, 
particularly overnight, were described as detrimental to 
relatives capacity to cope:
[home care] was never feasible unless we had much more 
support than we had, wed have to have [had] almost full 
time support. (R4)
youd have a job to get a nurse overnight. (R7)
GP involvement was also regarded as important. GPs 
who had been informed about the patients condition 
were said to have offered practical and emotional support 
to patients and relatives. However, the role of GPs could 
be constrained by poor or delayed communication with 
haematology staff:
[GP] came and said, well, I think weve reached the end of 
the road now  I knew the hospital kept him informed while 
[patient] was seeing [haematologist] and [GP] said, I can 
arrange for you to go into hospice, or if youd rather stay at 
home, the choice is up to you, and I said, oh, hell stay at 
home please, if I can have some help to look after him, and 
he said, yes, Ill arrange that for you. (R8)
they dont communicate with the GP surgeries, these 
specialist [haematology] centres. (R2)
Planning for, and timing of, hospital discharge was said 
to have a significant impact on resource availability and 
home death experiences. Advance planning, early involve-
ment of hospital palliative care staff and timely liaison 
between service providers were linked with positive 
experiences:
the hospital got in touch with Macmillan  When 
[haematologist] stopped treatment [he/she] wrote to our GP 
and [GP] took charge  and told us what was available  We 
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had a social worker come [who] got the care support forms 
going  carers coming in  we had Marie Curie come. (R3)
Contrastingly, relatives of patients discharged from 
hospital at short notice, when they were very close to 
death, reported insufficient time to organise support 
before the patients death; in some cases, patients did not 
survive long enough after treatment cessation to be dis-
charged home. Access to hospice beds at short notice was 
also regarded as problematic:
they sent him home  and he died [next day]  [community 
support] should be sorted before [he] came home from the 
hospital. (R7)
there was a meeting between the GP surgery and various 
staff at the hospital to try and have that [hospital discharge] 
happen  but unfortunately [patient] didnt reach that stage 
 (R10)
all these hospices are chock-a-block full, always. (R6)
Theme 3: suggested changes to facilitate 
care and death in the preferred place
Participants proposed various changes to promote attain-
ment of preferences. Early discussions of treatment cessa-
tion, prognosis and preferences were frequently 
mentioned:
it would have been a really good idea for someone to have 
[discussed prognosis] with her at a much earlier stage  it 
didnt really happen at all. (R9)
Having adequate community support (nursing services, 
reliable round-the-clock help; GP involvement), for both 
patients and carers, was also considered essential if rela-
tives were to cope satisfactorily at home and home death 
was to be achieved:
[the] Macmillan nurse was a gem  just telling us how to go 
about things  Marie Curie came to us about 4 times. (R3)
they could promise day care, but they couldnt promise night 
care  (R10)
he collapsed in the bathroom and I just couldnt lift him. (R1)
[the GP] got on to the district nurses  and he got a hospital 
bed  and hospice at home to help me. (R8)
the GP went out and did it [administered medication] at all 
hours  it was amazing  and just looked after the family. 
(R2)
Improved communication and co-ordination of ser-
vices across secondary and primary care, as well as third 
sector organisations (e.g. hospice), was also considered 
important in ensuring that appropriate support was 
available:
if they want people to die at home  they need to get it 
together  I think thats a big let-down, the communication 
between the hospital and the system outside. (R7)
no-one told me that he could have treatment at the hospice 
 I am sure we would have opted for hospice had we known 
that. (R10)
with the hospice, there needs to be a lot more interaction. 
(R1)
The final issue reported related to clinicians giving 
greater weight to relatives views on preventing hospital 
(re)admission of patients discharged home to die:
there was a real problem  with the out-of-hours service not 
understanding  and not being willing to listen  I accept 
that [the GPs] first reaction might be yes, lets get her into 
hospital, but [GP] should have stopped and listened  she 
died five days later at home. (R9)
Discussion
Main findings
Preferences were generally for death at home, but were 
not always achieved due to complex, interrelated factors, 
some amenable to change, others less so. Factors included 
the disease characteristics (e.g. the potential for sudden 
deterioration and death), occurrence and timing of dis-
cussions (e.g. treatment cessation, prognosis, place of 
care and death), family networks (e.g. the willingness/
ability of relatives to provide care, their awareness of ser-
vices and confidence to advocate on the patients behalf) 
and resource availability (e.g. clinical carers, hospice beds/
policies). On reflection, some relatives considered hospi-
tal the right place for the patient to have died. Others 
had shared strong preferences with patients for home 
death and acted to ensure this occurred. No patients died 
in a hospice, and a range of barriers were identified to 
this, notably lack of awareness about this facility, but also 
variation in service provision.
Strengths and weaknesses
To our knowledge, this is the first study to examine pre-
ferred place of care and death in patients with blood can-
cers from the perspective of bereaved relatives. Qualitative 
methods suit the exploration of phenomena about which 
little is known34 and purposeful sampling facilitated the 
selection of key informants who could provide rich 
description. Use of semi-structured interviews enabled 
relatives to focus on issues they considered significant. 
Our study sample, though comparatively small, is not 
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atypical in qualitative research.35 Determining the ideal 
number of participants is dependent on various factors, 
including the quality of information obtained from inter-
viewees.27,36 Participants in this study were the main care 
providers, so were inevitably well informed and able to 
relate rich, detailed data, which produced new and impor-
tant insights. The nature of the subject, and the relatively 
short space of time between the death of their relative 
and the interview, meant recall was not an issue, although 
the possible influence of memory on the validity of find-
ings cannot be completely dismissed. We recognise that 
the views of our study participants may not be reflective 
of the perspectives of the broader population of bereaved 
relatives;37 for example, the perceptions of relatives of 
younger patients, and those from minority ethnic groups, 
warrant further exploration.
What this study adds?
Our study provides new insights into end-of-life care for 
people with haematological malignancies. While almost 
all relatives said that they had shared patient preferences 
for home care/death, some indicated that they had come 
to regard place of death as less important than achieving 
the best care for their relative. Participants in our study 
who had come to regard hospital as the right place for 
the patients death said that this was due to the high-
quality care provided by well-known staff, in familiar sur-
roundings, and similar findings have been reported by 
others.38
Although a large body of research shows that home is 
generally the preferred place of death,39,40 many people 
do not die at home;16 for some, this may not be feasible or 
desirable.4143 Interestingly, a recent population-based 
study of haematological cancer decedents found that 
more than 28% of those reporting a preference opted for 
hospital death.44 In such situations, hospital may repre-
sent a safe haven.45 Freedom from pain, having family 
present, not being a burden, having treatment choices fol-
lowed and the opportunity to resolve conflicts have been 
ranked more highly by patients than actual place of 
death.46 Furthermore, review evidence indicates that 
what matters most to family members, regardless of the 
setting, is a good formal care team, who provide holistic 
round-the-clock assistance, keep relatives informed and 
acknowledge the significance of the informal carers 
role.47
Regarding factors impacting on achievement of prefer-
ences, disease characteristics were important, with 
unpredictable pathways constraining or shaping choices, 
decisions and outcomes. Sudden, unanticipated deterio-
ration was linked to increased likelihood of hospital death 
among patients having intensive hospital-based therapy, 
or receiving care at home. Relatives said that they would 
have welcomed guidance about the possibility of rapid 
change, as well as the signs of impending death. This issue 
has been highlighted by other authors,48 along with the 
difficulty of living in a state of permanent uncertainty 
about the way in which their relatives disease might pro-
gress and the moment of death.49
Preoccupation with doing the right thing when 
providing home care was widespread among our inter-
viewees and was linked to feelings of stress and inade-
quacy. Other authors have described the psychological 
complexity50 relatives report as inherent in providing 
home care, due to high levels of responsibility, isolation 
and anxiety, as well as emotions such as anger, fear, frus-
tration and sadness.49
Relatives in our study reported receiving varying levels 
of support from other family members and health profes-
sionals; those whose expectations for support had appar-
ently not been met appeared to harbour enduring feelings 
of disappointment. Literature suggests that family home 
carers are sometimes viewed as a co-workers by health 
care professionals and may not be identified as having 
their own needs; they may also be elderly, frail or ill them-
selves, requiring professionals to think family when 
assessing their support needs.47,51
The occurrence and timing of end-of-life discussions 
was significant. A widespread preference was stated for 
such conversations to occur early and for them to be 
open, honest and frank. Accounts of undue optimism 
about treatment outcomes among patients, relatives 
and haematologists may be due to previous success with 
multiple lines of therapy and overly optimistic interpre-
tation of communications with clinicians.52 Although 
maintaining some degree of hope, while remaining real-
istic, is a difficult balance,53,54 our findings underscore 
the need for clinicians to guard against raising false 
expectations.
There is growing consensus about the need for timely 
discussions55 and early shifts in treatment goals towards a 
palliative approach to care (including primary care involve-
ment), as the likelihood of response or cure dimin-
ishes.56,57 Prognostication is notoriously difficult in 
haematology,58 however, which complicates clinician deci-
sions regarding the best time to initiate advance plan-
ning. Moreover, relatives in our study often highlighted 
patients reluctance to talk about death and dying, a find-
ing that accords with studies showing that anxiety in such 
situations may trigger denial or avoidance behaviour.59,60 
Reasons cited in the wider literature to explain haematol-
ogists delays in initiating conversations include the pos-
sibility of response to new treatments, time constraints, 
lack of confidence in communicating bad news and disin-
clination to abandon patients after prolonged treat-
ments.61,62 Encouraging uptake of communication skills 
training among clinical staff could be one means of pro-
moting supportive, honest conversations and increasing 
patient and clinician satisfaction.63
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Relatives viewed the wider family network and depend-
able access to resources, including specialist palliative 
care and round-the-clock community nursing services, 
as crucial to supporting patients to die at home. This 
matches findings from a recent systematic review62 and 
reportedly results in home death becoming a more realis-
tic option.6466 GP involvement was seen as facilitative of 
home death, due to the multifaceted role these clinicians 
exert within primary care. The need for more effective 
communication systems across the primary/secondary 
care interface was also identified, along with greater 
acknowledgement of caregivers feelings and preferences, 
which may also promote their recovery from grief.67
Hospice services were not accessed by the majority of 
our interviewees and factors said to influence this 
(unavailability of urgent or routine beds/ access, policies 
for administrating supportive treatments and prior family 
knowledge/contact) are reported elsewhere.23,68 A recent 
US study69 concludes that patients would benefit from 
closer collaboration between haematology and palliative 
care doctors and hospice access. Increased collaboration 
has been noted in the United Kingdom, alongside the 
need for clearer role definition, and consistent, flexible 
service provision.24,61
Issues requiring further research identified in our own 
and other studies include the following: the extent to 
which relatives participate in multidisciplinary meetings, 
and the support they receive/require for this;70 the inter-
play between relatives and patients whose preferences 
differ and the implications of this for hospital (re)admission;71 
and GPs views of delivering end-of-life care to haematol-
ogy patients and their educational requirements.72
Conclusion
Our study highlights the factors that influence the attain-
ment of preferred place of care and death in patients with 
haematological malignancy and their relatives. Although 
most people expressed a preference for home death, not 
all achieved this, due to interrelated factors, some of 
which were amenable to change, and others less so. 
Death in hospital may be preferred and appropriate for 
some, or considered the best option in hindsight.
Acknowledgements
We wish to thank the study participants who took part in an 
interview and shared sensitive and emotive issues at a difficult 
time. We also thank David Brown the project steering group lay 
member and Ruth Hart (RH) for checking the coding of tran-
scripts. D.A.H., E.R., A.G.S., A.C.G. and M.R.H. designed the 
study. D.A.H. recruited the study participants and conducted 
interviews. Transcripts were coded and analysed by D.M. with 
discussion/input from D.A.H. D.M. wrote the first draft of the 
manuscript. D.A.H., E.R. and A.G.S. revised the manuscript. 
M.R.H., A.C.G., R.D.P. and M.J.J. commented on the clinical 
aspects of the study. All authors approved the final version.
Data sharing
All data and materials relating to this research are from the 
Haematological Malignancy Research Network and are archived 
and maintained according to organisational and ethical regula-
tions. Data are not publicly available due to the risk of partici-
pant identification from specific contexts revealed when reading 
entire transcripts and due to the terms and conditions regarding 
the release of data to third parties upon which ethical approvals 
for this study were contingent. Reasonable requests for further 
information relating to data can be made to the corresponding 
author.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with 
respect to the research, authorship and/or publication of this 
article.
Ethical approval
This study has NHS ethical approval (Yorkshire and the Humber 
Research Ethics Committee: 11/YH/0306).
Funding
The author(s) disclosed receipt of the following financial support 
for the research, authorship and/or publication of this article: 
This work was supported by the Marie Curie Research Grants 
Scheme (Grant Reference: C38860/A12554). The Haematological 
Malignancy Research Network was funded by Bloodwise (Grant 
Reference: 15037).
Informed consent
All participants were given verbal and written information about 
the study and their involvement. Written consent was obtained 
before interview and assurances given about confidentiality and 
anonymity. Participants were informed that they could with-
draw from the study at any time.
ORCID iDs
Miriam J Johnson  https://orcid.org/0000-0001-6204-9158
Debra A Howell  https://orcid.org/0000-0002-7521-7402
References
 1. Smith A, Howell D, Patmore R, et al. Incidence of hae-
matological malignancy by sub-type: a report from the 
Haematological Malignancy Research Network. Br J Cancer 
2011; 105(11): 16841692.
 2. National Cancer Intelligence Network. Trends in incidence 
and outcome for haematological cancers in England: 2001
2010. London: National Cancer Intelligence Network, 2014.
 3. National Institute for Health Care Excellence. Haemato-
logical cancers: improving outcomes, https://www.nice.org 
.uk/guidance/ng47/chapter/Recommendations (2016, 
accessed 8 March 2018).
 4. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision 
of the World Health Organization classification of lymphoid 
neoplasms. Blood 2016; 127(20): 23752390.
 5. Roman E, Smith A, Appleton S, et al. Myeloid malignancies 
in the real-world: occurrence, progression and survival in 
12 Palliative Medicine 00(0)
the UKs population-based Haematological Malignancy 
Research Network 2004-15. Cancer Epidemiol 2016; 42: 
186198.
 6. Smith A, Crouch S, Lax S, et al. Lymphoma incidence, sur-
vival and prevalence 20042014: sub-type analyses from 
the UKs Haematological Malignancy Research Network. Br 
J Cancer 2015; 112(9): 15751584.
 7. Henson LA, Gomes B, Koffman J, et al. Factors associated 
with aggressive end of life cancer care. Support Care Cancer 
2016; 24(3): 10791089.
 8. Ho TH, Barbera L, Saskin R, et al. Trends in the aggressive-
ness of end-of-life cancer care in the universal health care 
system of Ontario, Canada. J Clin Oncol 2011; 29(12): 1587
1591.
 9. Howell DA, Shellens R, Roman E, et al. Haematological 
malignancy: are patients appropriately referred for spe-
cialist palliative and hospice care? A systematic review and 
meta-analysis of published data. Palliat Med 2011; 25(6): 
630641.
 10. Dasch B, Kalies H, Feddersen B, et al. Care of cancer patients 
at the end of life in a German university hospital: a retro-
spective observational study from 2014. PLoS ONE 2017; 
12(4): e0175124.
 11. Hui D, Kim S-H, Kwon JH, et al. Access to palliative care 
among patients treated at a comprehensive cancer center. 
Oncologist 2012; 17(12): 15741580.
 12. Bennett MI, Ziegler L, Allsop M, et al. What determines 
duration of palliative care before death for patients with 
advanced disease? A retrospective cohort study of commu-
nity and hospital palliative care provision in a large UK city. 
BMJ Open 2016; 6(12): e012576.
 13. Howell DA, Roman E, Cox H, et al. Destined to die in hospi-
tal? Systematic review and meta-analysis of place of death 
in haematological malignancy. BMC Palliat Care 2010; 9: 9.
 14. Cohen J, Pivodic L, Miccinesi G, et al. International study of 
the place of death of people with cancer: a population-level 
comparison of 14 countries across 4 continents using death 
certificate data. Br J Cancer 2015; 113(9): 13971404.
 15. Gao W, Ho YK, Verne J, et al. Changing patterns in place of 
cancer death in England: a population-based study. PLoS 
Med 2013; 10(3): e1001410.
 16. Nilsson J, Blomberg C, Holgersson G, et al. End-of-life care: 
where do cancer patients want to die? A systematic review. 
Asia Pac J Clin Oncol 2017; 13(6): 356364.
 17. National End of Life Care Intelligence Network. What we 
know now 2014. London, 2015, http://www.endoflifecare-
intelligence.org.uk/resources/publications/what_we_
know_now_2014 (accessed 9 March 2018).
 18. Woodman C, Baillie J and Sivell S. The preferences and 
perspectives of family caregivers towards place of care 
for their relatives at the end-of-life. A systematic review 
and thematic synthesis of the qualitative evidence. BMJ 
Support Palliat Care 2016; 6(4): 418429.
 19. Hoare S, Morris ZS, Kelly MP, et al. Do patients want to die 
at home? A systematic review of the UK literature, focused 
on missing preferences for place of death. PLoS ONE 2015; 
10(11): e0142723.
 20. Milligan C, Turner M, Blake S, et al. Unpacking the impact 
of older adults home death on family care-givers experi-
ences of home. Health Place 2016; 38: 103111.
 21. Robinson J, Gott M, Gardiner C, et al. A qualitative study 
exploring the benefits of hospital admissions from the per-
spectives of patients with palliative care needs. Palliat Med 
2015; 29(8): 703710.
 22. Eagar K, Clapham SP and Allingham SF. Palliative care is 
effective: but hospital symptom outcomes superior. BMJ 
Support Palliat Care. Epub ahead of print 31 August 2018. 
DOI: 10.1136/bmjspcare-2018-001534.
 23. McCaughan D, Roman E, Smith AG, et al. Determinants of 
hospital death in haematological cancers: findings from a 
qualitative study. BMJ Support Palliat Care. Epub ahead of 
print 20 July 2017. DOI: 10.1136/bmjspcare-2016-001289.
 24. McCaughan D, Roman E, Smith AG, et al. Palliative care 
specialists perceptions concerning referral of haematology 
patients to their services: findings from a qualitative study. 
BMC Palliat Care 2018; 17(1): 33.
 25. Tong A, Sainsbury P and Craig J. Consolidated criteria for 
reporting qualitative research (COREQ): a 32-item check-
list for interviews and focus groups. Int J Qual Health Care 
2007; 19(6): 349357.
 26. Smith A, Howell D, Crouch S, et al. Cohort profile: the 
Haematological Malignancy Research Network (HMRN): 
a UK population-based patient cohort. Int J Epidemiol 
2018, https://academic.oup.com/ije/advance-article/
doi/10.1093/ije/dyy044/4958802 (accessed 3 May 2018).
 27. Morse JM. Determining sample size. Qual Health Res 2000; 
10(1): 35.
 28. Gale NK, Heath G, Cameron E, et al. Using the framework 
method for the analysis of qualitative data in multi-disci-
plinary health research. BMC Med Res Methodol 2013; 13: 
117.
 29. Green J and Thorogood N. Qualitative methods for health 
research. 4th ed. London: SAGE, 2018.
 30. Lincoln YS and Guba EG. Naturalistic inquiry. Newbury Park, 
CA: SAGE Publications, 1985.
 31. Barbour RS. Checklists for improving rigour in qualitative 
research: a case of the tail wagging the dog? BMJ 2001; 
322(7294): 11151117.
 32. Noble H and Smith J. Issues of validity and reliability in qual-
itative research. Evid Based Nurs 2015; 18(2): 3435.
 33. King N and Horrocks C. Interviews in qualitative research. 
London: SAGE, 2010.
 34. Mays M and Pope C (eds). Qualitative research in health 
care. Oxford: BMJ Books, 2006.
 35. Kim H, Sefcik JS and Bradway C. Characteristics of quali-
tative descriptive studies: a systematic review. Res Nurs 
Health 2017; 40(1): 2342.
 36. Malterud K, Siersma VD and Guassora AD. Sample size in 
qualitative interview studies: guided by information power. 
Qual Health Res. Epub ahead of print 27 November 2015. 
DOI: 10.1177/1049732315617444.
 37. Carminati L. Generalizability in qualitative research: a tale 
of two traditions. Qual Health Res 2018; 28(13): 2094
2101.
 38. Brazil K, Howell D, Bedard M, et al. Preferences for place of 
care and place of death among informal caregivers of the 
terminally ill. Palliat Med 2005; 19(6): 492499.
 39. Gomes B, Calanzani N, Gysels M, et al. Heterogeneity and 
changes in preferences for dying at home: a systematic 
review. BMC Palliat Care 2013; 12: 7.
McCaughan et al. 13
 40. Gomes B, Higginson IJ, Calanzani N, et al. Preferences for 
place of death if faced with advanced cancer: a population 
survey in England, Flanders, Germany, Italy, the Netherlands, 
Portugal and Spain. Ann Oncol 2012; 23(8): 20062015.
 41. Gomes B, Calanzani N, Koffman J, et al. Is dying in hospi-
tal better than home in incurable cancer and what factors 
influence this? A population-based study. BMC Med 2015; 
13: 235.
 42. Macleod U. Place of death: is home always best? Br J Hosp 
Med 2011; 72(8): 441443.
 43. Gott M, Seymour J, Bellamy G, et al. Older peoples views 
about home as a place of care at the end of life. Palliat Med 
2004; 18(5): 460467.
 44. Howell DA, Wang HI, Roman E, et al. Preferred and 
actual place of death in haematological malignancy. BMJ 
Support Palliat Care 2015, http://spcare.bmj.com/con-
tent/early/2015/07/08/bmjspcare-2014-000793.abstract 
(accessed 8 July 2015).
 45. Reyniers T, Houttekier D, Cohen J, et al. The acute hospital 
setting as a place of death and final care: a qualitative study 
on perspectives of family physicians, nurses and family car-
ers. Health Place 2014; 27: 7783.
 46. Steinhauser KE, Christakis NA, Clipp EC, et al. Factors con-
sidered important at the end of life by patients, family, 
physicians, and other care providers. JAMA 2000; 284(19): 
24762482.
 47. Morris SM, King C, Turner M, et al. Family carers providing 
support to a person dying in the home setting: a narrative 
literature review. Palliat Med 2015; 29(6): 487495.
 48. Harrop E, Morgan F, Byrne A, et al. It still haunts me 
whether we did the right thing: a qualitative analysis of 
free text survey data on the bereavement experiences and 
support needs of family caregivers. BMC Palliat Care 2016; 
15(1): 92.
 49. Martin JM, Olano-Lizarraga M and Saracibar-Razquin M. 
The experience of family caregivers caring for a terminal 
patient at home: a research review. Int J Nurs Stud 2016; 
64: 112.
 50. Totman J, Pistrang N, Smith S, et al. You only have one 
chance to get it right: a qualitative study of relatives expe-
riences of caring at home for a family member with termi-
nal cancer. Palliat Med 2015; 29(6): 496507.
 51. Turner M, King C, Milligan C, et al. Caring for a dying spouse 
at the end of life: its one of the things you volunteer for 
when you get married: a qualitative study of the oldest 
carers experiences. Age Ageing 2016; 45(3): 421426.
 52. McGrath P and Holewa H. Special considerations for hae-
matology patients in relation to end-of-life care: Australian 
findings. Eur J Cancer Care 2007; 16(2): 164171.
 53. Daneault S, Lussier V, Mongeau S, et al. The nature of suf-
fering and its relief in the terminally ill: a qualitative study. 
J Palliat Care 2004; 20(1): 711.
 54. Leung D, Esplen MJ, Peter E, et al. How haematological can-
cer nurses experience the threat of patients mortality. J 
Adv Nurs 2012; 68(10): 21752184.
 55. LeBlanc TW. Advance care planning and palliative care 
specialists in malignant hematology and stem-cell trans-
plantation: on why it takes a village. J Oncol Pract 2018; 
14(1): 35.
 56. LeBlanc TW, Roeland EJ and El-Jawahri A. Early palliative 
care for patients with hematologic malignancies: is it really 
so difficult to achieve? Curr Hematol Malig Rep 2017; 12(4): 
300308.
 57. Porta-Sales J, Guerrero-Torrelles M, Moreno-Alonso D, 
et al. Is early palliative care feasible in patients with multiple 
myeloma? J Pain Symptom Manage 2017; 54(5): 692700.
 58. Button E, Chan RJ, Chambers S, et al. A systematic review 
of prognostic factors at the end of life for people with a 
hematological malignancy. BMC Cancer 2017; 17(1): 213.
 59. Hoff L, Tidefelt U, Thaning L, et al. In the shadow of bad 
news  views of patients with acute leukaemia, myeloma 
or lung cancer about information, from diagnosis to cure or 
death. BMC Palliative Care 2007; 6: 1.
 60. Munday D, Petrova M and Dale J. Exploring preferences for 
place of death with terminally ill patients: qualitative study 
of experiences of general practitioners and community 
nurses in England. BMJ 2009; 339: b2391.
 61. Wright B and Forbes K. Haematologists perceptions of 
palliative care and specialist palliative care referral: a 
qualitative study. BMJ Support Palliat Care 2014; 7(1), 
http://spcare.bmj.com/content/early/2014/09/24/bmjsp-
care-2014-000689 (accessed 18 March 2015).
 62. Moreno-Alonso D, Porta-Sales J, Monforte-Royo C, et al. 
Palliative care in patients with haematological neoplasms: 
an integrative systematic review. Palliat Med 2018; 32(1): 
79105.
 63. Christie D and Glew S. A clinical review of communication 
training for haematologists and haemato-oncologists: a case 
of art versus science. Br J Haematol 2017; 178(1): 1119.
 64. Alonso-Babarro A, Astray-Mochales J, Dominguez-Berjon 
F, et al. The association between in-patient death, utiliza-
tion of hospital resources and availability of palliative home 
care for cancer patients. Palliat Med 2013; 27(1): 6875.
 65. Dixon J, King D, Matosevic T, et al. Equity in the provision of 
palliative care in the UK: review of evidence, https://www.
pssru.ac.uk/publications/pub-4962/ (2015, accessed 20 
March 2018).
 66. Riolfi M, Buja A, Zanardo C, et al. Effectiveness of palliative 
home-care services in reducing hospital admissions and 
determinants of hospitalization for terminally ill patients 
followed up by a palliative home-care team: a retrospec-
tive cohort study. Palliat Med 2014; 28(5): 403411.
 67. Holtslander L, Baxter S, Mills K, et al. Honoring the voices 
of bereaved caregivers: a metasummary of qualitative 
research. BMC Palliat Care 2017; 16(1): 48.
 68. Odejide OO, Cronin AM, Earle CC, et al. Why are patients 
with blood cancers more likely to die without hospice? 
Cancer 2017; 123(17): 33773384.
 69. Hochman MJ, Yu Y, Wolf SP, et al. Comparing the palliative 
care needs of patients with hematologic and solid malig-
nancies. J Pain Symptom Manage 2018; 55(1): 8288e1.
 70. Hudson P, Quinn K, OHanlon B, et al. Family meetings in 
palliative care: multidisciplinary clinical practice guidelines. 
BMC Palliat Care 2008; 7: 12.
 71. Ishikawa Y, Fukui S, Saito T, et al. Family preference for place 
of death mediates the relationship between patient pref-
erence and actual place of death: a nationwide retrospec-
tive cross-sectional study. PLoS ONE 2013; 8(3): e56848.
 72. Selman LE, Brighton LJ, Robinson V, et al. Primary care phy-
sicians educational needs and learning preferences in end 
of life care: a focus group study in the UK. BMC Palliat Care 
2017; 16(1): 17.
